TrialHuman vaccines & immunotherapeutics2023

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal.

Shipra Chaudhary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.